RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+1.97%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$327M
AUM Growth
-$10.4M
(-3.1%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
25.93%
Holding
105
New
8
Increased
44
Reduced
37
Closed
6
Top Buys
| 1 |
Universal Health Services
UHS
|
$7.18M |
| 2 |
Medtronic
MDT
|
$6.87M |
| 3 |
AbbVie
ABBV
|
$6.41M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$4.4M |
| 5 |
Alkermes
ALKS
|
$4.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$11.5M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$8.22M |
| 3 |
CELG
Celgene Corp
CELG
|
$7.28M |
| 4 |
Biogen
BIIB
|
$6.95M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$6.58M |
Sector Composition
| 1 | Healthcare | 82.32% |
| 2 | Financials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
51
DELISTED
Cerner Corp
CERN
| $2.38M | 0.7% |
40,000
+5,000
| +14% | +$298K |
|
52
Insulet
PODD
$24.2B
| $2.32M | 0.68% |
62,911
-37,089
| -37% | -$1.37M |
|
|
ARIA
53
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.28M | 0.67% |
423,000
+33,000
| +8% | +$178K |
|
54
Ionis Pharmaceuticals
IONS
$9.64B
| $2.25M | 0.66% |
58,000
+22,000
| +61% | +$854K |
|
|
CYBX
55
DELISTED
CYBERONICS INC
CYBX
| $2.2M | 0.64% |
43,000
-31,000
| -42% | -$1.59M |
|
56
Hologic
HOLX
$14.7B
| $2.19M | 0.64% |
90,000
+17,000
| +23% | +$414K |
|
|
AEGR
57
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $2.17M | 0.64% |
65,000
+23,069
| +55% | +$770K |
|
|
PRXL
58
DELISTED
Parexel International Corp
PRXL
| $2.15M | 0.63% |
34,000
-21,000
| -38% | -$1.32M |
|
|
ELGX
59
DELISTED
Endologix Inc
ELGX
| $2.12M | 0.62% |
20,000
-500
| -2% | -$53K |
|
|
AMSG
60
DELISTED
Amsurg Corp
AMSG
| $2.12M | 0.62% |
42,300
+15,000
| +55% | +$751K |
|
|
OREX
61
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.1M | 0.62% |
49,400
+19,380
| +65% | +$825K |
|
62
Edwards Lifesciences
EW
$47.7B
| $2.04M | 0.6% |
120,000
-90,000
| -43% | -$1.53M |
|
|
ITCI
63
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.04M | 0.6% |
149,000
+50,731
| +52% | +$696K |
|
|
CFN
64
DELISTED
CAREFUSION CORPORATION
CFN
| $2.04M | 0.6% |
45,000
-5,000
| -10% | -$226K |
|
|
RVNC
65
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.04M | 0.6% |
105,255
+23,255
| +28% | +$450K |
|
66
Esperion Therapeutics
ESPR
$490M
| $2.03M | 0.59% |
+82,921
| New | +$2.03M |
|
|
HPTX
67
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $2.03M | 0.59% |
80,369
+10,000
| +14% | +$252K |
|
|
ACHN
68
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2M | 0.58% |
200,000
-130,000
| -39% | -$1.3M |
|
69
Cigna
CI
$80.2B
| $2M | 0.58% |
22,000
-33,000
| -60% | -$2.99M |
|
|
INFI
70
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.99M | 0.58% |
148,000
+34,727
| +31% | +$466K |
|
|
CPHD
71
DELISTED
Cepheid Inc
CPHD
| $1.98M | 0.58% |
45,000
+10,000
| +29% | +$440K |
|
72
Eli Lilly
LLY
$661B
| $1.95M | 0.57% |
30,000
-14,500
| -33% | -$941K |
|
|
IMGN
73
DELISTED
Immunogen Inc
IMGN
| $1.91M | 0.56% |
180,000
+81,298
| +82% | +$861K |
|
|
NUVA
74
DELISTED
NuVasive, Inc.
NUVA
| $1.88M | 0.55% |
54,000
-22,000
| -29% | -$767K |
|
|
KERX
75
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.87M | 0.55% |
136,000
-104,000
| -43% | -$1.43M |
|